News

Fierce Biotech14m
Scancell picks winner from phase 2 cancer vaccine face off, choosing next-gen prospect for pivotal trial
Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...
Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement
Lyell Immunopharma's LYL314 CAR-T therapy shows durable responses in advanced LBCL patients. Learn about trials and upcoming ...
The Manila Times45m
Motorsport Games Releases Le Mans Ultimate Version 1.0, Featuring New Cars, Updated 2025 Content, and Additional Improvements
Motorsport Games Releases Le Mans Ultimate Version 1.0, Featuring New Cars, Updated 2025 Content, and Additional Improvements ...